中性粒细胞胞外诱捕网形成是静脉血栓栓塞患者隐匿性癌症的独立危险因素
研究纳入460例静脉血栓栓塞(VTE)患者,检测中性粒细胞胞外诱捕网(NETs)相关血液标志物,主要终点为一年随访期间诊断的癌症。排除43例入组时已知活动性癌症后,417例中29例(7.0%)随访期间诊断癌症;校正年龄和诱发性VTE后,H3Cit-DNA每增加500 ng/mL的癌症风险比为1.79(95%CI 1.03-3.10)。
要点
- H3Cit-DNA每增加500 ng/mL,随访期间癌症风险比为1.79(95%CI 1.03-3.10)。
- 癌症相关VTE患者H3Cit-DNA水平高于无癌症VTE患者,比值比2.06(95%CI 1.35-3.13)。
- H3Cit-DNA可能是VTE患者癌症诊断的有用标志物,NETs形成升高是癌症相关VTE的特征。
核心结论
- H3Cit-DNA是VTE患者隐匿性癌症的独立预测因子,且在癌症相关VTE中升高。
- H3Cit-DNA可能是VTE患者癌症诊断的有用标志物,NETs形成升高是癌症相关VTE的特征。
研究设计与样本
- 研究纳入460例VTE患者,其中221例(48%)为孤立性深静脉血栓形成。
- 43例入组时存在活动性癌症被排除于主要分析,主要分析人群为417例。
- 主要终点为一年随访期间诊断的癌症。
主要发现
- 417例患者中29例(7.0%)在随访期间诊断癌症。
- 校正年龄和诱发性VTE后,H3Cit-DNA每增加500 ng/mL的随访期间癌症风险比为1.79(95%CI 1.03-3.10)。
- 校正年龄、血红蛋白、性别、慢性阻塞性肺疾病、既往癌症和抗凝治疗开始后,癌症相关VTE患者H3Cit-DNA水平高于无癌症VTE患者,比值比2.06(每500 ng/mL增加,95%CI 1.35-3.13)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE), particularly unprovoked VTE, is associated with occult cancer. The optimal screening regimen remains controversial. Neutrophil extracellular traps (NETs) are implicated in cancer-associated thrombosis, and elevated biomarkers of NET formation are associated with poor prognosis. OBJECTIVES: To investigate the association between NET formation and occult cancer in patients with VTE. METHODS: Blood biomarkers associated with NETs and neutrophil activation (nucleosomal citrullinated histone H3 [H3Cit-DNA], cell-free DNA, and neutrophil elastase) were quantified in patients with VTE. The primary outcome was cancer diagnosed during a one-year follow-up. RESULTS: This study included 460 patients with VTE, of which 221 (48%) had isolated deep vein thrombosis. Forty-three patients had active cancer at inclusion and were excluded from the primary analysis Cancer during follow-up was diagnosed in 29 of 417 (7.0%) patients. After adjustment for age and unprovoked VTE, the hazard ratio of cancer during follow-up per 500 ng/mL increase of H3Cit-DNA was 1.79 (95% CI, 1.03-3.10). Furthermore, patients with cancer-associated VTE (known active cancer or cancer diagnosed during follow-up) had higher levels of H3Cit-DNA than cancer-free patients with VTE after adjustment for age, hemoglobin, gender, chronic obstructive pulmonary disease, previous cancer, and start of anticoagulant treatment (odds ratio 2.06 per 500 ng/mL increase of H3Cit-DNA [95% CI, 1.35-3.13]). CONCLUSIONS: H3Cit-DNA is an independent predictor for occult cancer in patients with VTE and elevated in cancer-associated VTE, suggesting that H3Cit-DNA is potentially a useful diagnostic marker for cancer in patients with VTE and that elevated NET formation is a hallmark of cancer-associated VTE.
引用
- Rosell A, Gautam G, Wannberg F, et al. Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolism. J Thromb Haemost. 2023. PMID: 37479035. doi:10.1016/j.jtha.2023.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。